Medicus Pharma Ltd (NASDAQ:MDCX) | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
Medicus Pharma Ltd

BRIEF

published on 09/18/2025 at 13:35, 2 months 16 days ago

Medicus Pharma obtient un financement de 8 millions de dollars pour le développement de médicaments

Cancer De La Prostate Financement Par Obligations Medicus Pharma Développement De Teverelix Antagoniste De La GnRH
BRIEF

published on 09/18/2025 at 13:35, 2 months 16 days ago

Medicus Pharma Secures $8 Million Financing for Drug Development

Prostate Cancer Debenture Financing Medicus Pharma Teverelix Development GnRH Antagonist
PRESS RELEASE

published on 09/18/2025 at 13:30, 2 months 16 days ago

Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing
Medicus Pharma Ltd. secures $8.0 million financing deal with Yorkville for the development of Teverelix, a GnRH Antagonist targeting Acute Urinary Retention and high CV risk Prostate Cancer

Clinical Development Financing Deal Medicus Pharma Ltd. GnRH Antagonist Teverelix
BRIEF

published on 09/08/2025 at 13:35, 2 months 26 days ago

Medicus Pharma lance une étude clinique pour le traitement du carcinome basocellulaire aux Émirats arabes unis

Essai Clinique Traitement Non Invasif Medicus Pharma Étude BCC Soins De Santé Aux Émirats Arabes Unis
BRIEF

published on 09/08/2025 at 13:35, 2 months 26 days ago

Medicus Pharma Commences Clinical Study for BCC Treatment in UAE

Non-invasive Treatment Clinical Trial Medicus Pharma BCC Study UAE Healthcare
PRESS RELEASE

published on 09/08/2025 at 13:30, 2 months 26 days ago

Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
Medicus Pharma Ltd. announces the commencement of patient recruitment for the SKNJCT-004 phase 2 clinical study at Cleveland Clinic Abu Dhabi to treat BCC of the skin non-invasively

Non-invasive Treatment Patient Recruitment Clinical Study Medicus Pharma Ltd. SKNJCT-004

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 52 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 57 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 27 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 22 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 27 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 27 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 57 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 36 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 2 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 12 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 12 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 27 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 27 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 42 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 42 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE